Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7546 AL 7560

Deep brain stimulation for intractable psychiatric disorders

Goodman WK, Alterman RL.

Annu Rev Med. 2012;63:511-24. doi: 10.1146/annurev-med-052209-100401. Epub 2011 Oct 27.

[A case of hemifacial spasm in a juglar foramen tumor patient treated by microvascular decompression]

Kamoshima Y, Terasaka S, Shimoda Y, Fukuda S, Houkin K.

No Shinkei Geka. 2011 Nov;39(11):1099-103.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

Fox SH, Katzenschlager R, Lim SY, Ravina B, Seppi K, Coelho M, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3:S2-41. doi: 10.1002/mds.23829.

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C.

Mov Disord. 2011 Oct;26 Suppl 3(0 3):S42-80. doi: 10.1002/mds.23884.

Drug-induced movement disorders and Syndenham's chorea in an antipsychotic-treated young child

Jadhav S, Coffey BJ.

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):487-90. doi: 10.1089/cap.2011.2157.

Dementia associated with Parkinson's disease: usefulness of the Movement Disorder Society diagnostic criteria in Brazil

Caramelli P.

Arq Neuropsiquiatr. 2011 Oct;69(5):731-2. doi: 10.1590/s0004-282x2011000600001.

Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder

Imai Y, Lu B.

Curr Opin Neurobiol. 2011 Dec;21(6):935-41. doi: 10.1016/j.conb.2011.10.016. Epub 2011 Nov 1.

A review of primary writing tremor

Rana AQ, Vaid HM.

Int J Neurosci. 2012 Mar;122(3):114-8. doi: 10.3109/00207454.2011.635827. Epub 2011 Dec 12.

Pharmacogenetics of response to antipsychotics in patients with schizophrenia

Arranz MJ, Rivera M, Munro JC.

CNS Drugs. 2011 Nov 1;25(11):933-69. doi: 10.2165/11595380-000000000-00000.

Biomarkers, genetics, and risk factors for concussion

Finnoff JT, Jelsing EJ, Smith J.

PM R. 2011 Oct;3(10 Suppl 2):S452-9. doi: 10.1016/j.pmrj.2011.07.014.

Parkinson's disease and dementia: a longitudinal study (DEMPARK)

Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R.

Neuroepidemiology. 2011;37(3-4):168-76. doi: 10.1159/000331490. Epub 2011 Nov 4.

Calcium channel blockers for neuroleptic-induced tardive dyskinesia

Essali A, Deirawan H, Soares-Weiser K, Adams CE.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD000206. doi: 10.1002/14651858.CD000206.pub3.

[Clinical characteristics of Rett Syndrome]

Abbes Z, Bouden A, Halayem S, Othman S, Bechir Halayem M.

Tunis Med. 2011 Oct;89(10):733-7.

Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B

Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ.

J Neuroimmunol. 2011 Dec 15;240-241:121-8. doi: 10.1016/j.jneuroim.2011.10.005. Epub 2011 Nov 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias